1.25

7.41% -0.10

After Hours: 1.30 0.05 +4.00%

Cardiff Oncology Inc (CRDF)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cardiff Oncology Inc stock is traded at $1.25, with a volume of 907.08K. It is down -7.41% in the last 24 hours and down -16.67% over the past month. Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

Previous Close:

$1.35

Open:

$1.31

24h Volume:

907.08K

Relative Volume:

0.76

Market Cap:

$85.46M

Revenue:

$525.00K

Net Income/Loss:

$-44.76M

P/E Ratio:

-1.8791

EPS:

-0.6652

Net Cash Flow:

$-37.46M

1W Performance:

-3.10%

1M Performance:

-16.67%

6M Performance:

-60.57%

1Y Performance:

-68.27%

1-Day Range:

$1.23

$1.36

1-Week Range:

$1.20

$1.37

52-Week Range:

$1.16

$4.555

Cardiff Oncology Inc Stock (CRDF) Company Profile

Name

Cardiff Oncology Inc

Sector

Healthcare (1094)

Industry

Biotechnology (614)

Phone

858-952-7570

Address

11055 FLINTKOTE AVENUE, SAN DIEGO, CA

Employee

Twitter

@cardiffoncology

Next Earnings Date

2026-08-04

Latest SEC Filings

CRDF's Discussions on Twitter

Compare CRDF vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRDF Cardiff Oncology Inc	1.25	92.30M	525.00K	-44.76M	-37.46M	-0.6652
VRTX Vertex Pharmaceuticals Inc	498.43	132.55B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	662.88	70.90B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	915.30	57.21B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	323.50	42.94B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.77	40.49B	742.00K	-1.37B	-1.07B	-7.0731

Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-26	Initiated	Noble Capital Markets	Outperform
Jul-08-25	Initiated	Ladenburg Thalmann	Buy
Jun-24-25	Initiated	Jefferies	Hold
Sep-06-24	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	William Blair	Outperform
Dec-08-21	Initiated	Robert W. Baird	Outperform
Aug-09-21	Resumed	Maxim Group	Buy
Oct-22-20	Initiated	H.C. Wainwright	Buy
Oct-08-20	Initiated	Piper Sandler	Overweight

View All

Cardiff Oncology Inc Stock (CRDF) Latest News

Jul 07, 2026

Price to earnings forward of Cardiff Oncology, Inc. – TRADEGATE:XE7C - TradingView

Jul 07, 2026

Jul 05, 2026

Price to book forward of Cardiff Oncology, Inc. – NASDAQ:CRDF - TradingView

Jul 05, 2026

Jul 04, 2026

CRDFCardiff Oncology Inc Dividends - Finviz

Jul 04, 2026

Jun 30, 2026

Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential? - Yahoo Finance

Jun 30, 2026

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM:CRDF) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Dynamic Index - marketscreener.com

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM:CRDF) dropped from Russell Small Cap Completeness Index - marketscreener.com

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2500 Index - marketscreener.com

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 3000 Index - marketscreener.com

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Index - marketscreener.com

Jun 29, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 28, 2026

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

5 Most Promising Cancer Stocks According to Wall Street Analysts - Insider Monkey

Jun 28, 2026

Jun 27, 2026

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director TANNENBAUM RENEE P - Moomoo

Jun 27, 2026

Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W - Moomoo

Jun 27, 2026

Jun 26, 2026